Sleep Epilepsy drug reduces sleep apnea symptoms by up to 50 per cent in clinical trial Sleeping with a noisy breathing machine remains one of the biggest frustrations for people with obstructive sleep apnea. However, researchers said an older epilepsy... Joseph Morton2 days ago
Medical and Pharmaceutical Medtronic spin-out MiniMed lists on Nasdaq, attains EU approval for diabetes tech MiniMed makes insulin delivery and glucose monitoring devices Rowan Dunne2 days ago
Medical and Pharmaceutical Monash University’s medical engineering institute progresses silicosis breath test Its MedTech Commercialisation Advancement Program has been expediting the tool's development Rowan Dunne6 days ago
Medical and Pharmaceutical Optellum breaks new ground with TGA approval for AI-powered lung nodule solution 'Radiological computer-assisted diagnostic software for lesions suspicious of cancer' is what the FDA calls it Rowan DunneMarch 5, 2026
Medical and Pharmaceutical Minnesota’s Vocxi Health and Forj Medical report success with lung cancer breath test It uses nanosensors and AI algorithms to detect volatile organic compounds linked to the disease Rowan DunneMarch 3, 2026
Sleep Sleep apnea specialist Resmed announces plans for major new distribution centre Constructing the Greenwood, Indiana facility will cost the company US$30 million Rowan DunneMarch 2, 2026
Medical and Pharmaceutical GRAIL plunges hard after ‘Galleri’ multi-cancer test fails to meet primary endpoint The slide comes in tandem with financial results that beat expectations Rowan DunneFebruary 20, 2026
Medical and Pharmaceutical Biotech operator Personalis sees 10% spike from Medicare covering lung cancer blood test The ctDNA blood draw is known for its ultrasensitive detection capabilities Rowan DunneFebruary 10, 2026
Medical and Pharmaceutical European Lung Cancer Screening Alliance to launch this month News of the upcoming debut came the day before World Cancer Day, Feb. 4 Rowan DunneFebruary 4, 2026
Medical and Pharmaceutical Philadelphia hospital initiates research partnership with canine cancer detection specialist ‘SpotitEarly’ Fox Chase Cancer Center will be leading a multi-year clinical study assessing SpotitEarly's lung cancer test Rowan DunneFebruary 2, 2026